Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Randomized, Observer-blind, Placebo-controlled Trial of a Haemophilus Influenzae Serotype A (Hia) Glycoconjugate Vaccine With Alum Adjuvant in Young Adults 18 to 40 Years of Age

NCT06465420 is registered in ClinicalTrials.gov with InventVacc Biologicals Inc. as lead sponsor.

NCT NCT06465420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06465420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Randomized, Observer-blind, Placebo-controlled Trial of a Haemophilus Influenzae Serotype A (Hia) Glycoconjugate Vaccine With Alum Adjuvant in Young Adults 18 to 40 Years of Age
Lead sponsor
InventVacc Biologicals Inc.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 29, 2024
Completion date
September 15, 2025
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilus influenzae meningitis, invasive haemophilus influenzae disease